CTMX
CytomX Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.05 / 10
Outperform
Technically, CTMX scores 6.05/10, with Long Lower Shadow (6.35) and Long Upper Shadow (8.66) indicating strong bullish momentum, while MACD Death Cross (7.9) confirms trend strength. Marubozu White (1.31) is a minor bearish outlier. Recent patterns over the last five days show a mix of bullish and neutral signals, leading to a cautiously optimistic outlook for short-term traders.
Analysis Checks(3/4)
Long Lower Shadow
Score6.35/10
Win Rate52.31%
Hist. Signals65
Avg Return6.10%
Score6.35/10
Win Rate52.31%
Hist. Signals65
Avg Return6.10%
MACD Death Cross
Score7.9/10
Win Rate66.67%
Hist. Signals12
Avg Return5.92%
Score7.9/10
Win Rate66.67%
Hist. Signals12
Avg Return5.92%
Long Upper Shadow
Score8.66/10
Win Rate67.74%
Hist. Signals62
Avg Return9.31%
Score8.66/10
Win Rate67.74%
Hist. Signals62
Avg Return9.31%
Marubozu White
Score1.31/10
Win Rate33.33%
Hist. Signals9
Avg Return0.22%
Score1.31/10
Win Rate33.33%
Hist. Signals9
Avg Return0.22%
Long Lower Shadow
Score6.35/10
Win Rate52.31%
Hist. Signals65
Avg Return6.10%
Score6.35/10
Win Rate52.31%
Hist. Signals65
Avg Return6.10%
Long Upper Shadow
Score8.66/10
Win Rate67.74%
Hist. Signals62
Avg Return9.31%
Score8.66/10
Win Rate67.74%
Hist. Signals62
Avg Return9.31%
MACD Death Cross
Score7.9/10
Win Rate66.67%
Hist. Signals12
Avg Return5.92%
Score7.9/10
Win Rate66.67%
Hist. Signals12
Avg Return5.92%
Marubozu White
Score1.31/10
Win Rate33.33%
Hist. Signals9
Avg Return0.22%
Score1.31/10
Win Rate33.33%
Hist. Signals9
Avg Return0.22%
Technical Analysis of CTMX?
- CTMX presents a Outperform setup with a Technical Score of 6.05/10. Key technical indicators highlight an RSI of 58.09 and a MACD of -0.06, with the trend anchored by the 50-Day SMA at 4.60. Traders should monitor key support at 4.99 and resistance at 5.67.
